GlassScriptPhysician profile
Joseph D'Angelo
NPI 1780702043
$6,728.94
in general payments reported to CMS, 2019-2025
13 companies · $297 in 2025
The $297 reported for 2025 was more than what 83% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,515 · 2021: $80.22 · 2022: $4,223 · 2023: $302 · 2024: $311 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662 · Gift: $198 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.05 |
| Gift | $198.25 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $4,289.84 | 2021-2025 | Invisalign |
| Sirona Dental, INC. | $750.00 | 2019 | |
| Patterson Companies, INC. | $750.00 | 2019 | |
| Zimvie INC. | $253.15 | 2022-2024 | |
| A-Dec, INC. | $198.25 | 2025 | |
| Straumann USA LLC | $135.10 | 2022-2023 | |
| Dentsply Sirona INC | $107.12 | 2021-2024 | Astra Tech Implant System, Atlantis, Cavitron |
| Kerr Corporation | $76.99 | 2023 | Tf Adaptive |
| Nobel Biocare USA | $76.98 | 2023 | Nobelactive |
| Solventum Corporation | $31.91 | 2025 | 3m Relyx, 3m Clinpro, 3m Scotchbond |
| 3m Company | $30.02 | 2021-2023 | 3m Espe Filtek Supreme Ultra Universal Restorative, Filtek |
| Orapharma, A Division of Bausch Health US, LLC | $15.44 | 2019 | |
| Peter Brasseler Holdings, LLC | $14.14 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph D'Angelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.